Skip to main content

MoneyWorks4Me

USFDA completes inspection at Granules India’s Hyderabad facility

17 Feb 2020 Evaluate

US Food and Drug Administration (USFDA) has completed inspection at Granules India’s facility in Gagillapur located in Hyderabad, Telangana, India on February 14, 2020 with two observations. The company will respond to these observations within the stipulated time.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..